Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
PMID:

Abstract

BACKGROUND: There is a need for clinically actionable prognostic and predictive tools to guide the management of oligometastatic castration-sensitive prostate cancer (omCSPC).

Authors

  • Jarey H Wang
    Johns Hopkins University, Baltimore, MD, USA.
  • Matthew P Deek
    Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
  • Adrianna A Mendes
    Department of Pathology, Johns Hopkins University School of Medicine.
  • Yang Song
    Biomedical and Multimedia Information Technology (BMIT) Research Group, School of IT, University of Sydney, NSW 2006, Australia. Electronic address: yson1723@uni.sydney.edu.au.
  • Amol Shetty
    University of Maryland Medical Center, Baltimore, MD, USA.
  • Soha Bazyar
    University of Maryland Medical Center, Baltimore, MD, USA.
  • Kim Van der Eecken
    Ghent University Hospital, Ghent, Belgium.
  • Emmalyn Chen
    Artera, Inc., Los Altos, CA.
  • Timothy N Showalter
    Artera Inc., Los Altos, CA, USA; University of Virginia, Charlottesville, VA, USA.
  • Trevor J Royce
    Artera Inc., Los Altos, CA, USA.
  • Tamara Todorovic
    Artera Inc., Los Altos, CA, USA.
  • Huei-Chung Huang
    Artera, Inc., Los Altos, CA.
  • Scott A Houck
    Artera Inc., Los Altos, CA, USA.
  • Rikiya Yamashita
    Artera, Inc., Los Altos, CA.
  • Ana P Kiess
    Johns Hopkins University, Baltimore, MD, USA.
  • Daniel Y Song
    Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
  • Tamara Lotan
    Johns Hopkins University, Baltimore, MD, USA.
  • Theodore DeWeese
    Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland.
  • Luigi Marchionni
    Weill Cornell Medicine, New York, NY, USA.
  • Lei Ren
    Department of Biomaterials, College of Materials, Xiamen University, Xiamen 361005, P.R. China.
  • Amit Sawant
    Radiation Oncology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
  • Nicole Simone
    Thomas Jefferson University, Philadelphia, PA, USA.
  • Alejandro Berlin
    Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Cem Onal
    Baskent University Faculty of Medicine, Adana Dr Turgut Noyan Research and Treatment Center, Department of Radiation Oncology, Adana, Turkey; Baskent University Faculty of Medicine, Department of Radiation Oncology, Ankara, Turkey. Electronic address: hcemonal@hotmail.com.
  • Andre Esteva
    Artera, Inc., Los Altos, CA.
  • Felix Y Feng
    Department of Radiation Oncology, University of California, San Francisco, San Francisco.
  • Phuoc T Tran
    Department of Radiation Oncology, University of Maryland School of Medicine, Baltimore.
  • Philip Sutera
    Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Piet Ost
    Department of Human Structure and Repair, Ghent University, Ghent, Belgium; Department of Radiation Oncology, Iridium Network, Antwerp, Belgium. Electronic address: piet.ost@ugent.be.